Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1/2 1Phase 1 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 88INDUSTRY 5NIH 4OTHER_GOV 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Plasma cell 1Breast 1

Conditions

Recurrence 2Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Ascorbic Acid × Clear all
NCT04150042 2026-01-29

SHARON

General Oncology, Inc.

Phase 1 Recruiting
24 enrolled
BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT02206425 2023-10-31

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

Oncotherapeutics

Phase 1/2 Completed
45 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT05932511 2023-08-30

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Unknown
15 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Neoplasms, Squamous Cell

NCT05174845 2022-05-31

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

Norgine

Completed
13,393 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms

NCT04279535 2021-11-02

Topical Vitamin C for Treatment of Basal Cell Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Completed
25 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡